FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer April 20, 1999 No Comments
SBR-170: a new bioreductive alkylating agent selected for further evaluation April 20, 1999 No Comments
News from AACR: 9-NC does not require conversion to 9-AC to exert antitumor activity April 19, 1999 No Comments
NX-211 compared to free lurtotecan regarding pharmacokinetics, toxicity and efficacy April 19, 1999 No Comments
CD-437: new apoptogenic retinoid examined for resistance using leukemia cells April 19, 1999 No Comments
RSS